Literature DB >> 18668310

Postprandial hyperglycemia after a gastrectomy and the prediabetic state: a comparison between a distal and total gastrectomy.

Hiroshi Yamamoto1, Hiroshi Tsuchihashi, Hiroya Akabori, Hiroyuki Naitoh, Hiroshi Maegawa, Tohru Tani.   

Abstract

PURPOSE: Postprandial hyperglycemia is recognized as an important risk factor for developing type 2 diabetes; it is also common in patients after a gastrectomy and is likely to become exacerbated after a total gastrectomy rather than after a distal gastrectomy. In this study, we investigated the glucose and insulin responses after oral glucose tolerance test (OGTT), and compared the incidence of postchallenge hyperglycemia after OGTT in patients after a distal and total gastrectomy.
METHODS: Forty-six patients, including 18 patients after a distal gastrectomy and 28 after a total gastrectomy, underwent a 75-g OGTT, and the plasma concentrations of glucose and insulin were measured after OGTT.
RESULTS: Glucose peaked at 30 min in the distal gastrectomy patients and 60 min in the total gastrectomy patients, and there were significant differences in the 1-h plasma glucose (PG) and 1.5-h PG levels between the distal and total gastrectomy patients. Insulin peaked at 60 min in both the distal and total gastrectomy patients, and there were significant differences in insulin levels at 60 min between the distal and total gastrectomy patients. The incidence of postchallenge hyperglycemia in the patients after a total gastrectomy (57.1%) was higher than in those after distal gastrectomy (27.8%). Moreover, significant positive correlations were found between 1-h PG and hemoglobin antigen HbA1c after a total gastrectomy but not after a distal gastrectomy.
CONCLUSIONS: These results suggest that postchallenge hyperglycemia after OGTT may become more exacerbated after a total gastrectomy than after a distal gastrectomy. Postprandial hyperglycemia, especially after a total gastrectomy, may therefore be involved in the development of diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668310     DOI: 10.1007/s00595-007-3711-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

Review 1.  Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus).

Authors:  Markolf Hanefeld
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

2.  A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Authors:  Hiroshi Yamamoto; Tsuyoshi Mori; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naito; Tohru Tani
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Ileocolon interposition as a substitute stomach after total or proximal gastrectomy.

Authors:  T Sakamoto; M Fujimaki; K Tazawa
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

4.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

5.  Hyperglycemia after gastrectomy as a prediabetic state. Clinical study of 100 postgastrectomy patients.

Authors:  T Tobe; M Kouchi; H Tanimura; C H Huang
Journal:  Arch Surg       Date:  1967-06

6.  Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.

Authors:  M Emoto; Y Nishizawa; K Maekawa; Y Hiura; H Kanda; T Kawagishi; T Shoji; Y Okuno; H Morii
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

7.  Failure of nutritional recovery after total gastrectomy.

Authors:  F T Curran; G L Hill
Journal:  Br J Surg       Date:  1990-09       Impact factor: 6.939

8.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

9.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

Authors:  H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

10.  Vector autoregressive modeling analysis of frequently sampled oral glucose tolerance test results. 2. Insulin resistance and secretion after gastrectomy.

Authors:  K Ito; T Wada; H Makimura; A Matsuoka; H Maruyama; T Saruta
Journal:  Keio J Med       Date:  1998-06
View more
  4 in total

1.  Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus.

Authors:  Woohyung Lee; Sang Hoon Ahn; Jue Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

2.  Does Roux-en-Y gastrectomy for gastric cancer influence glucose homeostasis in lean patients?

Authors:  Silvia Y Hayashi; Joel Faintuch; Osmar K Yagi; Camila M Yamaguchi; Jacob J Faintuch; Ivan Cecconello
Journal:  Surg Endosc       Date:  2013-02-23       Impact factor: 4.584

3.  Comparing the Effectiveness of Total Gastrectomy and Gastric Bypass on Glucose Metabolism in Diabetic Rats.

Authors:  Donglei Zhou; Xun Jiang; Wei Jian; Lijun Zheng; Liesheng Lu; Chengzhu Zheng
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

4.  Bypassed and Preserved Stomach Resulted in Superior Glucose Control in Sprague-Dawley Rats with Streptozotocin-Induced Diabetes.

Authors:  Jason Widjaja; Ponnie Robertlee Dolo; Qiang Zhang; Libin Yao; Chao Li; Jian Hong; Hui Wang; Song Meng; Yong Shao; Xiaocheng Zhu
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.